Trials / Completed
CompletedNCT01200576
A Prospective Observational Study of the Clinical Performance of Zarin in Madagascar
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 621 (actual)
- Sponsor
- FHI 360 · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
This one-year observational study will monitor the contraceptive effectiveness, safety and acceptability of Zarin during the first year of use after the method has been approved for public use in Madagascar. It will be implemented by Marie Stopes Madagascar with technical support from Marie Stopes International and FHI. 300 women of reproductive age who selected Zarin as their primary method of contraception will be enrolled in the study at the MSM outreach sites and static clinics.
Detailed description
This one-year observational study will monitor the contraceptive effectiveness, safety and acceptability of Zarin during the first year of use after the method has been approved for public use in Madagascar. It will be implemented by Marie Stopes Madagascar with technical support from Marie Stopes International and FHI. 300 women of reproductive age who selected Zarin as their primary method of contraception will be enrolled in the study at the MSM outreach sites and static clinics.
Conditions
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-02-01
- Completion
- 2012-03-01
- First posted
- 2010-09-13
- Last updated
- 2013-03-29
Locations
1 site across 1 country: Madagascar
Source: ClinicalTrials.gov record NCT01200576. Inclusion in this directory is not an endorsement.